Literature DB >> 26041329

Clinical and immunologic effects of maraviroc in progressive multifocal leukoencephalopathy.

Ananja Middel1, Joop E Arends2, Steven F L van Lelyveld1, Sigrid Otto1, Rob Schuurman1, Catharina J M Frijns1, Kiki Tesselaar1, Andy I M Hoepelman1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26041329     DOI: 10.1212/WNL.0000000000001713

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

1.  Not a Disease of the Past: A Case Series of Progressive Multifocal Leukoencephalopathy in the Established Antiretroviral Era.

Authors:  Nathan A Summers; Colleen F Kelley; Wendy Armstrong; Vincent C Marconi; Minh Ly Nguyen
Journal:  AIDS Res Hum Retroviruses       Date:  2019-04-03       Impact factor: 2.205

Review 2.  Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.

Authors:  S A Misbah
Journal:  Clin Exp Immunol       Date:  2017-03-27       Impact factor: 4.330

3.  Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and maraviroc in a patient with idiopathic CD4 lymphocytopenia.

Authors:  Asaff Harel; Sam Horng; Tarah Gustafson; Anil Ramineni; Rebecca Straus Farber; Michelle Fabian
Journal:  J Neurovirol       Date:  2018-07-09       Impact factor: 2.643

Review 4.  Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.

Authors:  Deanna Saylor; Arun Venkatesan
Journal:  Curr Infect Dis Rep       Date:  2016-11       Impact factor: 3.725

5.  Progressive multifocal leukoencephalopathy and black fungus in a patient with rheumatoid arthritis without severe lymphocytopenia.

Authors:  Marieke J A de Regt; Jean-Luc Murk; Tilman Schneider-Hohendorf; Mike P Wattjes; Andy I M Hoepelman; Joop E Arends
Journal:  JMM Case Rep       Date:  2016-08-30

Review 6.  Progressive Multifocal Leukoencephalopathy in Children with Primary and Secondary Immune Deficiency.

Authors:  Asuman Demirbuğa; Ozge Kaba; Selda Hançerli Törün; Edibe Pembegül Yıldız; Esra Yücel; Ayper Somer
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2021-06-17       Impact factor: 0.885

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.